Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959

This article has now been updated. Please use the final version.

Consensus on the diagnosis of Cushing’s disease: a collaborative statement from the Korean Endocrine Society and Japan Endocrine Society
Jeongmin LeeHidenori FukuokaSeung Shin ParkA Ram HongJung Hee KimSang Ouk ChinHan-Sang BaekDong-Jun LimKazunori KageyamaMitsuru NishiyamaShigeyuki TaharaKen-Ichi OyamaAkira SugawaraMiho YamashitaNaoko InoshitaHiroshi ArimaByung-Joon KimYoon-Sok ChungSoon Jib YooMichio Otsuki Mi-kyung Kim The Committee of Clinical Practice Guideline of Korean Endocrine SocietyKorean Neuroendocrine Study Group of Korean Endocrine Society
Author information
JOURNAL OPEN ACCESS Advance online publication
Supplementary material

Article ID: EJ25-0492

Details
Abstract

Cushing’s disease (CD) is a rare but serious endocrine disorder caused by excessive cortisol secretion due to adrenocorticotropic hormone–secreting pituitary tumors. Despite recent developments in diagnostic criteria and treatment options, CD remains associated with substantial comorbidities and mortality. Early and accurate diagnosis is thus essential. Both the Korean Endocrine Society (KES) and Japan Endocrine Society (JES) guidelines are intended to standardize diagnostic approaches to CD, and they share common principles; however, notable differences exist, particularly in biochemical testing thresholds and imaging recommendations. This consensus statement integrates clinical evidence and expert practice from both the KES and JES to establish harmonized recommendations for biochemical evaluation, imaging, and differential testing. This unified framework is intended to enhance diagnostic precision and improve clinical outcomes across East Asian populations.

Content from these authors
© The Japan Endocrine Society

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
feedback
Top